News in Numbers

Continuous glucose monitoring system distributor DexCom’s stock fell over 38% after revising its annual revenue forecast to $4bn from its previous estimate of $4.2bn-$4.35bn.

Becton, Dickinson and Company (BD) has announced that roughly 200 jobs will be axed following the 2026 closure of its facility in Drogheda, Ireland.

Saudi Arabia’s King Faisal Specialist Hospital & Research Centre (KFSH&RC) reported a 98% survival rate for 400 robotic cardiac surgeries performed at the hospital, since programme initiation in February 2019.

Shares in Autonomix Medical rose by 34% after it entered an agreement to licence intellectual property for RF Innovations’s ablation technology.

The first patient enrolled in a clinical trial of Amber Therapeutics deep brain stimulation device for epilepsy experienced an 80% reduction in daytime seizures after using the device.